NKIND Stock Overview
N.K Industries Limited engages in the manufacture, sale, and trading of castor oil and its derivatives in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
N.K Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹53.95 |
| 52 Week High | ₹94.40 |
| 52 Week Low | ₹35.05 |
| Beta | -0.29 |
| 1 Month Change | -1.10% |
| 3 Month Change | -23.69% |
| 1 Year Change | 30.95% |
| 3 Year Change | 93.37% |
| 5 Year Change | 54.14% |
| Change since IPO | 35.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| NKIND | IN Food | IN Market | |
|---|---|---|---|
| 7D | -2.1% | 1.3% | 1.8% |
| 1Y | 30.9% | 21.2% | 46.4% |
Price Volatility
| NKIND volatility | |
|---|---|
| NKIND Average Weekly Movement | 5.7% |
| Food Industry Average Movement | 7.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 201 | Priyam Patel | www.nkindustriesltd.com |
N.K Industries Limited engages in the manufacture, sale, and trading of castor oil and its derivatives in India. Its products portfolio includes castor oil British pharma 93 grade, cold pressed castor oil, commercial grade castor oil, first pressed degummed castor oil, first special grade-F S.G refined castor oil, and pale pressed grade refined castor oil; DE oiled cake and high protein castor meal; oil derivatives, as such 12-hydroxy stearic acid and hydrogenated castor oil flakes/powder, and ricinoleic acid; crude glycerin; and sodium sulfate anhydrous.
N.K Industries Limited Fundamentals Summary
| NKIND fundamental statistics | |
|---|---|
| Market cap | ₹322.91m |
| Earnings (TTM) | -₹17.93m |
| Revenue (TTM) | ₹183.60m |
1.8x
P/S Ratio-18.0x
P/E RatioIs NKIND overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NKIND income statement (TTM) | |
|---|---|
| Revenue | ₹183.60m |
| Cost of Revenue | ₹19.39m |
| Gross Profit | ₹164.20m |
| Other Expenses | ₹182.14m |
| Earnings | -₹17.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | -2.98 |
| Gross Margin | 89.44% |
| Net Profit Margin | -9.77% |
| Debt/Equity Ratio | 0% |
How did NKIND perform over the long term?
See historical performance and comparison